{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:11:34Z","timestamp":1789071094862,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbmt.2018.03.028","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T13:28:15Z","timestamp":1522848495000},"page":"1776-1782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Control of Cytomegalovirus Viremia after Allogeneic Stem Cell Transplantation: A Review on CMV-Specific T Cell Reconstitution"],"prefix":"10.1016","volume":"24","author":[{"given":"Pim","family":"van der Heiden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Marijt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Falkenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Jedema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2018.03.028_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1749-6632.1995.tb31041.x","article-title":"Bone marrow transplantation from bench to bedside","volume":"770","author":"Thomas","year":"1995","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.bbmt.2018.03.028_bib0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"25","author":"Ljungman","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"10.1016\/j.bbmt.2018.03.028_bib0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1399-3062.2009.00411.x","article-title":"Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases","volume":"11","author":"Styczynski","year":"2009","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.bbmt.2018.03.028_bib0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1083-8791(00)70051-6","article-title":"Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome","volume":"6","author":"Koc","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bbmt.2018.03.028_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002889","article-title":"Deep sequencing of antiviral T-cell responses to HCMV and EBV in humans reveals a stable repertoire that is maintained for many years","volume":"8","author":"Klarenbeek","year":"2012","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.bbmt.2018.03.028_bib0035","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.bbmt.2018.03.028_bib0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.bbmt.2018.03.028_bib0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcv.2014.11.033","article-title":"Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications","volume":"63","author":"Korndewal","year":"2015","journal-title":"J Clin Virol"},{"issue":"5","key":"10.1016\/j.bbmt.2018.03.028_bib0050","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1182\/blood.V97.5.1232","article-title":"Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation","volume":"97","author":"Cwynarski","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbmt.2018.03.028_bib0055","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1182\/blood.V98.5.1358","article-title":"Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection","volume":"98","author":"Gratama","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bbmt.2018.03.028_bib0060","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1182\/blood.V99.10.3830","article-title":"Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation","volume":"99","author":"Hebart","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bbmt.2018.03.028_bib0065","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbmt.2009.03.022","article-title":"Increased programmed death-1 molecule expression in cytomegalovirus disease and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation","volume":"15","author":"Gallez-Hawkins","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1\u20132","key":"10.1016\/j.bbmt.2018.03.028_bib0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cellimm.2014.02.007","article-title":"Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation","volume":"288","author":"Kato","year":"2014","journal-title":"Cell Immunol"},{"issue":"2","key":"10.1016\/j.bbmt.2018.03.028_bib0075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","article-title":"Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity","volume":"101","author":"Boeckh","year":"2003","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bbmt.2018.03.028_bib0080","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00277-016-2711-1","article-title":"Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016","volume":"95","author":"Ullmann","year":"2016","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.bbmt.2018.03.028_bib0085","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/S2352-3026(15)00289-6","article-title":"Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study","volume":"3","author":"Green","year":"2016","journal-title":"Lancet Haematol"},{"issue":"2","key":"10.1016\/j.bbmt.2018.03.028_bib0090","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/bmt.2014.229","article-title":"Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time","volume":"50","author":"Parody","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bbmt.2018.03.028_bib0095","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00277-011-1351-8","article-title":"Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus","volume":"91","author":"Liu","year":"2012","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.bbmt.2018.03.028_bib0100","first-page":"78","article-title":"Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation","volume":"91","author":"Ljungman","year":"2006","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.bbmt.2018.03.028_bib0105","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbmt.2009.02.009","article-title":"Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation","volume":"15","author":"Nakamae","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bbmt.2018.03.028_bib0110","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/bmt.2009.180","article-title":"Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience","volume":"45","author":"Pinana","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.bbmt.2018.03.028_bib0115","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cmi.2015.06.009","article-title":"Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality","volume":"21","author":"Liu","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.bbmt.2018.03.028_bib0120","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.bmt.1705385","article-title":"Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath \u201cin the bag\u201d as T-cell depletion: the Leiden experience","volume":"37","author":"Barge","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2018.03.028_bib0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bmt.1705701","article-title":"Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning","volume":"40","author":"Kalpoe","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2018.03.028_bib0130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbmt.2016.11.003","article-title":"Mixed T cell chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia using an alemtuzumab-containing regimen is shaped by persistence of recipient CD8 T cells","volume":"23","author":"Grimaldi","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.bbmt.2018.03.028_bib0135","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/ajh.23319","article-title":"Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation","volume":"87","author":"El-Cheikh","year":"2012","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.bbmt.2018.03.028_bib0140","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00007890-198804000-00018","article-title":"T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation","volume":"45","author":"Hale","year":"1988","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.bbmt.2018.03.028_bib0145","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V66.3.664.664","article-title":"Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts","volume":"66","author":"Martin","year":"1985","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbmt.2018.03.028_bib0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/0003-4819-105-1-20","article-title":"Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial","volume":"105","author":"Mitsuyasu","year":"1986","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.bbmt.2018.03.028_bib0155","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood.V98.10.2942","article-title":"Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)","volume":"98","author":"Bacigalupo","year":"2001","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.bbmt.2018.03.028_bib0160","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2010-05-286856","article-title":"Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution","volume":"116","author":"Chakraverty","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbmt.2018.03.028_bib0165","first-page":"597","article-title":"Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases","volume":"13","author":"Hale","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bbmt.2018.03.028_bib0170","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1399-3062.2007.00235.x","article-title":"Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation","volume":"9","author":"Almyroudis","year":"2007","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.bbmt.2018.03.028_bib0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bmt.1704334","article-title":"Influence of cytomegalovirus (CMV) sero-positivity on CMV infection, lymphocyte recovery and non-CMV infections following T-cell-depleted allogeneic stem cell transplantation: a comparison between two T-cell depletion regimens","volume":"33","author":"Chakrabarti","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bbmt.2018.03.028_bib0180","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbmt.2010.07.020","article-title":"Donor serostatus has an impact on cytomegalovirus-specific immunity, cytomegaloviral disease incidence, and survival in seropositive hematopoietic cell transplant recipients","volume":"17","author":"Ugarte-Torres","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bbmt.2018.03.028_bib0185","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.bbmt.2016.05.020","article-title":"Impact of donor and recipient cytomegalovirus serostatus on outcomes of antithymocyte globulin-conditioned hematopoietic cell transplantation","volume":"22","author":"Kalra","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bbmt.2018.03.028_bib0190","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu364","article-title":"Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation","volume":"59","author":"Ljungman","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.bbmt.2018.03.028_bib0195","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1182\/blood-2013-05-499830","article-title":"CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT","volume":"122","author":"Schmidt-Hieber","year":"2013","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.bbmt.2018.03.028_bib0200","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1182\/blood-2009-02-203307","article-title":"Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients","volume":"113","author":"Zhou","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bbmt.2018.03.028_bib0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cmi.2015.11.006","article-title":"Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status","volume":"22","author":"Servais","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.bbmt.2018.03.028_bib0210","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1399-3062.2011.00626.x","article-title":"Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Borchers","year":"2011","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.bbmt.2018.03.028_bib0215","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1182\/blood-2014-07-589150","article-title":"CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status","volume":"125","author":"Sellar","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbmt.2018.03.028_bib0220","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1182\/blood-2005-07-2746","article-title":"Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications","volume":"107","author":"Chalandon","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bbmt.2018.03.028_bib0225","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3324\/haematol.2012.072264","article-title":"T-cell reconstitution after allogeneic stem cell transplantation: assessment by measurement of the sjTREC\/betaTREC ratio and thymic naive T cells","volume":"98","author":"Ringhoffer","year":"2013","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.bbmt.2018.03.028_bib0230","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2007-05-092130","article-title":"Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing","volume":"110","author":"Komanduri","year":"2007","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.bbmt.2018.03.028_bib0235","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1182\/blood-2012-09-453720","article-title":"Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo","volume":"121","author":"McGoldrick","year":"2013","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.bbmt.2018.03.028_bib0240","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1182\/blood-2011-06-361618","article-title":"Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients","volume":"118","author":"Milano","year":"2011","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.bbmt.2018.03.028_bib0245","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood-2012-08-448977","article-title":"Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation","volume":"121","author":"Blyth","year":"2013","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.bbmt.2018.03.028_bib0250","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bbmt.2018.03.028_bib0255","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/mt.2013.151","article-title":"Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant","volume":"21","author":"Gerdemann","year":"2013","journal-title":"Mol Ther"},{"issue":"9","key":"10.1016\/j.bbmt.2018.03.028_bib0260","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.bbmt.2015.05.015","article-title":"Immunotherapy with donor T cells sensitized with overlapping pentadecapeptides for treatment of persistent cytomegalovirus infection or viremia","volume":"21","author":"Koehne","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.bbmt.2018.03.028_bib0265","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jcyt.2015.07.005","article-title":"Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Ma","year":"2015","journal-title":"Cytotherapy"},{"issue":"8","key":"10.1016\/j.bbmt.2018.03.028_bib0270","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/CJI.0b013e31826e35f6","article-title":"Effective treatment of refractory CMV reactivation after allogeneic stem cell transplantation with in vitro-generated CMV pp65-specific CD8+ T-cell lines","volume":"35","author":"Meij","year":"2012","journal-title":"J Immunother"},{"issue":"6","key":"10.1016\/j.bbmt.2018.03.028_bib0275","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbmt.2007.02.004","article-title":"Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Micklethwaite","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"242","key":"10.1016\/j.bbmt.2018.03.028_bib0280","doi-asserted-by":"crossref","first-page":"242ra283","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.bbmt.2018.03.028_bib0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/ciq042","article-title":"Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation","volume":"52","author":"Peggs","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.bbmt.2018.03.028_bib0290","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1086\/648422","article-title":"Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation","volume":"49","author":"Peggs","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9393","key":"10.1016\/j.bbmt.2018.03.028_bib0295","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","article-title":"Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines","volume":"362","author":"Peggs","year":"2003","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.bbmt.2018.03.028_bib0300","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.bbmt.2018.03.028_bib0305","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00430-008-0093-2","article-title":"CD8 T-cell-based immunotherapy of cytomegalovirus infection: \u201cproof of concept\u201d provided by the murine model","volume":"197","author":"Holtappels","year":"2008","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.bbmt.2018.03.028_bib0310","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.bbmt.2018.03.028_bib0315","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.immuni.2014.05.018","article-title":"Serial transfer of single-cell-derived immunocompetence reveals stemness of CD8(+) central memory T cells","volume":"41","author":"Graef","year":"2014","journal-title":"Immunity"},{"issue":"6132","key":"10.1016\/j.bbmt.2018.03.028_bib0320","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.1235454","article-title":"Disparate individual fates compose robust CD8+ T cell immunity","volume":"340","author":"Buchholz","year":"2013","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bbmt.2018.03.028_bib0325","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/blood-2013-12-547349","article-title":"Lowest numbers of primary CD8(+) T cells can reconstitute protective immunity upon adoptive immunotherapy","volume":"124","author":"Stemberger","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bbmt.2018.03.028_bib0330","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.immuni.2007.10.012","article-title":"A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets","volume":"27","author":"Stemberger","year":"2007","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.bbmt.2018.03.028_bib0335","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/CJI.0b013e318181b4bd","article-title":"Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy","volume":"31","author":"Fujita","year":"2008","journal-title":"J Immunother"},{"issue":"9","key":"10.1016\/j.bbmt.2018.03.028_bib0340","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1182\/blood-2003-09-3056","article-title":"Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants","volume":"103","author":"Rauser","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bbmt.2018.03.028_bib0345","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jcyt.2014.05.023","article-title":"Clinical-scale isolation of \u201cminimally manipulated\u201d cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease","volume":"16","author":"Odendahl","year":"2014","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.bbmt.2018.03.028_bib0350","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1537-2995.2010.02940.x","article-title":"Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation","volume":"51","author":"Schmitt","year":"2011","journal-title":"Transfusion"},{"issue":"26","key":"10.1016\/j.bbmt.2018.03.028_bib0355","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1182\/blood-2015-08-664755","article-title":"TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells","volume":"126","author":"Menger","year":"2015","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.bbmt.2018.03.028_bib0360","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.bbmt.2018.03.028_bib0365","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bbmt.2018.03.028_bib0370","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1038\/leu.2017.16","article-title":"Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT","volume":"31","author":"Neuenhahn","year":"2017","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.bbmt.2018.03.028_bib0375","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.4049\/jimmunol.0902233","article-title":"CMV-specific TCR-transgenic T cells for immunotherapy","volume":"183","author":"Schub","year":"2009","journal-title":"J Immunol"},{"issue":"285","key":"10.1016\/j.bbmt.2018.03.028_bib0380","doi-asserted-by":"crossref","first-page":"285ra263","DOI":"10.1126\/scitranslmed.aaa2546","article-title":"CMV-specific T cells generated from naive T cells recognize atypical epitopes and may be protective in vivo","volume":"7","author":"Hanley","year":"2015","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.bbmt.2018.03.028_bib0385","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3324\/haematol.2010.039099","article-title":"Successful generation of primary virus-specific and anti-tumor T-cell responses from the naive donor T-cell repertoire is determined by the balance between antigen-specific precursor T cells and regulatory T cells","volume":"96","author":"Jedema","year":"2011","journal-title":"Haematologica"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118301629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118301629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:03:17Z","timestamp":1761058997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879118301629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":76,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1083879118301629"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.03.028","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Control of Cytomegalovirus Viremia after Allogeneic Stem Cell Transplantation: A Review on CMV-Specific T Cell Reconstitution","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}